Activation of Langerhans-Type Dendritic Cells Alters Human Cytomegalovirus Infection and Reactivation in a Stimulus-Dependent Manner.
Oral mucosal Langerhans cells (LC) are likely to play important roles in host defense against infection by human cytomegalovirus (CMV). We previously showed that in vitro-differentiated immature LC (iLC) populations contain smaller amounts of infected cells but produce higher yields than mature LC (mLC) cultures, obtained by iLC stimulation with fetal bovine serum (FBS), CD40 ligand (CD40L) and lipopolysaccharide (LPS). Here, we sought to determine if exposure to select stimuli can improve LC permissiveness to infection, if specific components of the mLC cocktail are responsible for lowering viral yields, if this is due to defects in progeny production or release, and if these restrictions are also effective against reactivated virus. None of the stimuli tested extended the proportion of infected cells to 100%, suggesting that the block to infection onset cannot be fully removed. While CD40L and FBS exerted positive effects on viral progeny production per cell, stimulation with LPS alone or in combination with CD40L was detrimental. Reductions in viral titers were not due to defects in progeny release, and the permissive or restrictive intracellular environment established upon exposure to each stimulus appeared to act in a somewhat similar way toward lytic and latent infections.
Center for Immunobiology and Vaccine Development, Children's Hospital Oakland Research Institute Oakland, CA, USA.
Roxanne
R
Coronel
Center for Immunobiology and Vaccine Development, Children's Hospital Oakland Research Institute Oakland, CA, USA.
Desyree M
DM
Jesus
Center for Immunobiology and Vaccine Development, Children's Hospital Oakland Research Institute Oakland, CA, USA.
Lucia
L
Dalle Ore
Department of Microbiology and Immunology and Department of Oncology, The University of Western Ontario London, ON, Canada.
Joe S
JS
Mymryk
Center for Immunobiology and Vaccine Development, Children's Hospital Oakland Research Institute Oakland, CA, USA.
Laura
L
Hertel
cytomegalovirus; dendritic cells; host defense; infection restrictions; langerhans cells
J Gen Virol. 1993 Nov;74 ( Pt 11):2333-8
8245850
Trends Mol Med. 2008 May;14(5):191-8
18396104
J Gen Virol. 1996 Dec;77 ( Pt 12):3099-102
9000102
J Oral Maxillofac Pathol. 2013 Sep;17(3):329-33
24574647
Inflamm Res. 2006 Jul;55(7):293-9
16955392
J Virol. 1989 Jul;63(7):3026-33
2542610
J Gen Virol. 2010 Mar;91(Pt 3):599-604
19906945
Proc Natl Acad Sci U S A. 2002 Mar 19;99(6):3932-7
11867761
Clin Exp Immunol. 1999 Jan;115(1):153-60
9933436
J Infect Dis. 1999 Feb;179(2):484-8
9878035
Aust Dent J. 1995 Feb;40(1):46-9
7710416
Oral Microbiol Immunol. 2006 Aug;21(4):256-60
16842511
Allergy. 2008 Jun;63(6):720-7
18445186
N Am J Med Sci. 2013 Sep;5(9):505-14
24251267
J Gen Virol. 2005 Nov;86(Pt 11):2949-54
16227215
Transpl Infect Dis. 1999 Sep;1(3):157-64
11428986
J Virol. 2013 Oct;87(19):10660-7
23885077
Br J Haematol. 2004 Aug;126(3):410-7
15257715
Eur J Immunol. 2003 Jun;33(6):1528-38
12778470
J Biol Chem. 2012 Aug 3;287(32):26702-14
22711534
J Virol. 1994 Jun;68(6):4017-21
8189535
Blood. 2004 Jun 1;103(11):4207-15
14962896
J Virol. 2014 Jan;88(1):403-16
24155395
J Virol. 2003 Jul;77(13):7563-74
12805456
J Clin Periodontol. 1998 Dec;25(12):1003-7
9869350
EMBO J. 1989 Dec 20;8(13):4251-8
2556267
J Virol. 2012 Aug;86(16):8507-15
22647696
Anat Cell Biol. 2015 Sep;48(3):177-87
26417477
Transplantation. 1994 Sep 27;58(6):675-80
7940686
J Virol. 2011 Dec;85(23):12750-8
21937636
J Dent Res. 2006 Aug;85(8):678-89
16861283
Proc Natl Acad Sci U S A. 1998 Mar 31;95(7):3937-42
9520471
Proc Natl Acad Sci U S A. 2007 Nov 27;104(48):19061-6
18006657
Anticancer Res. 2001 Jan-Feb;21(1A):113-7
11299724
J Oral Pathol Med. 1994 Feb;23(2):55-9
8164153
Exp Lung Res. 1998 Jan-Feb;24(1):3-14
9457465
Nucleic Acids Res. 1992 Jul 11;20(13):3287-95
1385862
Crit Rev Oral Biol Med. 1996;7(1):36-58
8727106
Antiviral Res. 2011 Jun;90(3):151-9
21439328
Proc Natl Acad Sci U S A. 2010 Nov 16;107(46):20039-44
21041645
Virology. 1995 Apr 1;208(1):197-206
11831701
Eur J Immunol. 1997 Dec;27(12):3135-42
9464798
Allergy. 2006 Feb;61(2):166-72
16409191
Blood. 1997 Sep 15;90(6):2482-91
9310501
J Allergy Clin Immunol. 2003 Jul;112(1):141-8
12847491
J Oral Pathol Med. 1989 Oct;18(9):510-6
2481737
J Virol. 1999 Jun;73(6):4806-12
10233941
Rev Med Virol. 2010 Nov;20(6):372-9
20931610
J Virol. 2015 May;89(10):5615-32
25762731
Proc Natl Acad Sci U S A. 2005 Mar 15;102(11):4140-5
15738399
Mediators Inflamm. 1998;7(5):319-25
9883966
Cell Death Differ. 2006 Apr;13(4):672-5
16311507